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Abさtract
Several observations were made on the tissue culture of Toxoplasma gondii (RH
strain) with use of HeLa cells for a host cell line, with the object of obtaining the
fundamental knowledge of the growth of the parasite in the tissue culture. To
assess the growth of the parasite in the tissue culture, the infection rate of HeLa
cells and the relative number of infective parasites were counted: the former was
expressed by the percentage value of the number of HeLa cells invaded by the
parasite, among the total HeLa cells observed, and the latter by the total number of
parasites found in 100 HeLa cells on a microscope. Results achieved were summariz-
ed as below:
1) The infection rate of HeLa cells ascended up to 6 hours after the parasite
inoculation into the HeLa cell culture, then trended to a gradual descent. The
relative number of infective parasites was found to keep a rise up to 9 hours after
the parasite inoculation into the culture.
2) The addition of lysozyme (1 mg/ml or more) or hyaluronidase (6 units/ml or
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more) into the tissue culture of the parasite brought about an increase of the infec-
tion rate of HeLa cells as well as the relative number of infective parasites.
3) The pretreatment of the parasite with sulfisoxazole (10 mg/ml) for 4 hours
or sulfathiazole (10 mg/ml) for 2 hours shortly before the parasite inoculation into
the HeLa cell culture did not appear to inhibit the growth of the parasite in a 6-hour
cultivation.
4) The pretreatment of the parasite with 1% of the HA (Hemagglutination test)
-positive human serum (HA-titre 4,096•~) or 0.01% of the rabbit immune serum
(HA-titre 65,536•~) for 30 minutes or longer resulted in a noticeable reduction of

























培養を用い, Chernin & Weller (1954, 1957)およ



























牛血清10%, Penicillin lOOu/ml., Streptomycin
lOOγ/ml, (以下HLSと略す)を加え, pH 7.2-
7.3に修正し, 4℃　の冷蔵庫に保存したものを用い
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Table 1. Composition of tissue culture medium

















(C). 0.2% Phenol red 100 ml
Culture medium
(A). Hanks' solution
(10-fold concentration) 50 ml
Aq. dest. 450 ml
7.5% NaHCOs 2.0 ml
Penicillin (200,000 U/5ml) 1.25 ml
Streptomycin (1.0 g/5ml) 0.25 ml
(B). 5/o Lactalbumin hydrolysate 50 ml
(C). Bovine serum 50 ml
PH7.2~7.3
4.
HeLa Hfi^W^rft, ifftffi^ 5.0x10.0
cm2 (DftM C^«) ^fflW, HeLa «O HLS
#$$ 15 ml *#&U ^Agrtr^iJfL, 37n ^
iiia^»ff o fc. «^m©&atfriSI:£SI«^-eS
H |g^ L, »BJ!§^^)g<Dfli?Ö£ftfc-MffirfiS*^
^^^^^, ^^-C*^|?g^i|-C, 0.25% Trypsin
-Jt (Puck?g?n 0.25%<D Trypsin %-^tf) ^jHx.
"ClffllS^^^Md^ilJilL, 1,200 rpm (^200G),
5^-^^fe^, ±^^^T, W Hanks ^trJtJfc^
JiL, ±»^^*T, HLS ^TOT§»»fpf},
tffc^^iDE^^a L-Tmw%m*ft ->fc.
Tp aiiJtS^fcfe^^^^; HeLa SiJJS^ft-eti,
Jt^ffiitlfflSS^*Ö^5 3.0x5.0 cm2 (/j^ffi) co^J
ffi^, ffl/iif?* (1.5x1.0 cm2) ^Ah, HeLa
MBS HLS |?iiS 5 ml &#8ELt:, 37"C
tt^frofc. TP ^Sit^mi^^-r ^ftLfc^^,
HeLa MSgO 48!^^^^©%O^.Hife-fS - i^L
fc.
5. J^^CD^*
-^̂ ^Jfijert^ RH fto Tp (MA^^IO6) ^r^
S-fSt, -KbjfJfe-x-^ttaS 4-5 H^gii
LtJEtrtSj&s Kmomttm^, &SKJ&&&
1 ml ^Ii^[*j^£AL, d^ilWjti L-t:, ffi*
5 £E&t> £< oit7jc^«i-;&. »LfcI
it 800 rpm (^100 G), S^^JtJfeLt:,
m«iiafiofflti»£L, jh-;t$t©^ £ <2Ki
3,000 rpm (=d,500 G), lOSHHjtJfeLt, Tp JK&
^M-^L^, £ <OgfeJSlC Hanks Tf^Bxi, J^iC
LTic&»i^fF£. ??^JI^^^jfli«ft»«^ffi
v ^tr^^ u /ff^^-iS-^^ftf^ Lfc.
6. Utt^a
$^ **Jg;fcJ: <J £fc&Lfc TP ^^^i LX,
HLS ^ri sH^ffit-M^f^!? , J5r»fc«-t
S. -ÖJI^^^?S^^*^*4i L"C, UTo^^^
ffo fc.
1) ?|£$ISt*&5 HeLa 0J!S^^O Tp OMA
te*Ji O*Tp Ji^M^o^Tli^Ly-c.
2) Lysozyme(Worthington Bioch, Corp.Öá")
4 fc«Hyaluronidase(|fffljl^^ 7°7 ~-tf&$l »fc)
^^Mi'C^iaL, Tp J§^^fci^-f^S^||^L/c.
3) -tfvL-7 r^IJ i LtT, N'-3, 4-Dimethyl-5-iso-
xazol sulfanilamide (lH±|*l$i^, -^à"1' Te/v^^
V^fc. JiTF Sulfisoxazole iI3ft), ^oi^ Sulfa-
thiazole-N4* sodium dextrosesulfonate (lljSM^.
-^/L"/~^S^j^l^c. UT Sulfathiazole ilSft,
^ffllfi-t^t: Sulfathiazole M i LT^aLfc) ^
J^\ i^Ubt Tp i^^ftBf^^^^lSl^L*, ^r
O^O Tp ^Jl^l^feSj^^^^H-S^^ti^Lfc.
4) #i Tp ^m^lSlftLiftfctt Tp *jfil3t^*K
JCE (Tp HA-test) ^ittAlfllit^ffil\ 3) ©^il^
«©Sft^tT ofc.
-KbO^^c^T, jfitft*sJ:tfiM'7 T£!l£ Tp
<hO^M^(^(:O^P< mELfc. />H^I =iyu-<y^t?
Tp <Dl%^-m^M Hanks S^itÖ^, -^-^Ojfll
mti-c^mM^M^, 37°C VC^gL, )Df^BtFs^^
^<0-tl^MI^M^U E^^- Hanks?g"t*2 HI
jt^^l L-tll b^fc Tp ff-^«:i§»t*4i Lfc.
tfc, Tp CO HeLa $J3§[*!-\<DItAt4*JiO5 Tp
Ji3feffiÖ¥iJ^i&©& t:£?£Ki i o fc.
^, lattf^^x^lX^ffiL, Hanks it^t:-1~2HI
ig< i5feJiL, gfiT^^H$-^fc^, fttyjc^ ^ / -/u
à"e@>£, ¥A-y-*?g-e^j 4o#f^feLfc. M*©^S
f^, ^^-^Vs/n^-At;-^,7/f KA"v^^^C,














































for HeLa cells and the
parasites on tnei rec-
tangular g一ass stained
もy Giemsa's so一ution



















































Fig. 2. Growth curve of HeLa cells.
























































lnfect言on rate of HeLa ce】ーs













































Fig. 3.　Number of parasites in the liquid part of culture medium




































Fig. 4. Hourly measurement of the infection
rate of HeLa cells with differed num-










































































Fig. 5. The infection rate of HeLa cells and
the relative number of infective para-
sites･
(Notes) Solid line : Relative number of
infective parasites















































Hf41 Hyaluronidase 500 ^ife (unit) ^rf^ %
©t*&5. ^{CflJ^fc Tp M&jggfi 190X10V
ml "C, Hyaluronidase }£ 6 u/ml ^fJ;CK 60u/'ml





























P arasite number inoculated '.
260 x 104/ml
3 6 9 (Hours)
Fig. 6. The infection rate of HeLa cells by














Parasite number inoculated '.
260 x 104/ml
3 6 9 (Hours)
Fig. 7. Relative number of infective parasites
by the addition of Lysozyme into the
culture medium.
if8*?iZ>'if9HKi Hyaluronidase <D-^b He-
La &&$%&&£& Tp j&%&*&L-fc*><D-e, m
&gft^3, 6 *Jj;<yf gStfml^J, Hyaluronidase
60 u/ml CD^KLJ^T, HeLa «g|g|fe2^£
^MM^JtL, ^-^ft l.Sfg, 1.2fg, 1.2fgi^^,
6 u/ml o^^-r^t^^MW-ibt, ^^^^i^i>
l^TFLfc. tfc Tp ^^feiJC^-C%Hyaluronidase
&M^M#!R-.tfc L, M £MCRI ^§:1t^^Lfc.
MS ^ O^IfeX'ffiM ^^Lfc^S^^O Lysozyme fc
itf Hyaluronidase oM^tl, "fHHg^tC-^t:,
HeLa Ifflgg oifJftfe i t>*ii!ffllS «D^^Kli&r b ^^^g^




















P arasite number inoculated '. 190 x loVml
Fig. 8. The infection rate of HeLa cells by











3 6 9 (Hours)
Fig. 9. The relative number of infective pa-
ratites by the addition of Hyaluroni-


















































































Fig. 10. Length of the pretreatment of parasi.
tes with Sulfisoxazole and the relati-
ve number of infective parasites.
Note : The concentration of Sulfiso-











































































Fig. ll. Length of the pretreatment of parasi-
tes with Sulfathiazole and the relative
number of infective parasites.
Note : The concentration of Sulfathia-









































































Fig. 12. Length of the pretreatment of parasi-
tes with the HA-positive human serum



























































Fig. 13. Length of the pretreatment of parasi-
tes with the rabbit immune serum






















































































Fig. 14. Length of the pretreatment of parasi-
tes with the rabbit immune serum






























ならない.これに関して, Guimar急es and Meyer


















































































2) Lysozyme (1 mg/ml以上)またほHyalu-
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